Does Mounjaro Cause Hair Loss?
- Gwen Adey
- Jun 7
- 4 min read
The Short Answer
If a patient asked me whether Mounjaro, Wegovy or Ozempic cause hair loss, my answer would be:
Probably not directly.
I suspect the weight loss is usually the more important factor than the medication itself.
Many people notice increased hair shedding while taking Mounjaro (tirzepatide), Wegovy (semaglutide) or Ozempic (semaglutide).
The shedding is real.
The question is whether the medication is causing it.
At the moment, the best explanation is that the rapid weight loss these medications can produce may trigger a condition called telogen effluvium - a (usually) temporary form of hair shedding that has long been recognised after significant weight loss, surgery, illness and other physical stresses.
That does not prove the medications play no role.
Researchers are still trying to untangle where the effects of the drugs end and where the effects of rapid weight loss begin.
However, based on the evidence currently available, we think the most likely explanation for many cases is the weight loss rather than a direct effect on hair follicles.
Why Do I Say That?
Patients taking Mounjaro, Wegovy and Ozempic have increasingly reported hair shedding.
Several studies have found signals suggesting hair loss may occur more frequently in people taking these medications.
At first glance, that sounds worrying.
But there is an important question that must be asked.
Is the medication causing the hair loss?
Or is the weight loss causing the hair loss?
Those are not the same thing.
Imagine two patients.
One loses four stone after bariatric surgery.
Another loses four stone using Mounjaro.
Both develop increased hair shedding three months later.
If the pattern of hair loss is identical, the common factor may not be the treatment itself.
The common factor may be the rapid weight loss.
This is why many hair specialists currently believe that much of the hair shedding seen with these medications is likely to represent telogen effluvium.
What Is Telogen Effluvium?
Telogen effluvium is a temporary form of hair shedding that occurs when a stress causes a larger number of hair follicles than usual to enter the resting phase of the hair cycle.
Several months later, those hairs are shed.
Common triggers include:
Major illness
Surgery
Childbirth
Severe psychological stress
Crash dieting
Rapid weight loss
The important thing to understand is that the shedding does not usually happen immediately.
There is often a delay of several months between the trigger and the hair falling out.
This timing fits surprisingly well with many reports from patients taking Mounjaro, Wegovy and Ozempic.
Could The Medications Still Be Involved?
Possibly.
Although rapid weight loss is currently the leading explanation, scientists have not completely ruled out the possibility that the medications themselves may play some role.
Several large database studies have reported associations between GLP-1 medications and different forms of hair loss.
However, these studies cannot prove cause and effect. They can only tell us that two things appeared together more often than expected.
That is not the same as proving that one caused the other.
At present, there is no convincing evidence that semaglutide or tirzepatide directly damage human hair follicles.
Could Nutritional Deficiencies Be Part Of The Story?
Possibly.
When people lose weight rapidly, they often eat less food overall.
That can sometimes reduce intake of protein, iron and other nutrients important for healthy hair growth.
Some researchers have suggested this may contribute to hair shedding in certain individuals.
Again, this points towards weight loss and nutrition as potential explanations rather than a direct toxic effect of the medication itself.
What Do We Do When Patients Come To See Us with Hair Loss While or After Taking Mounjaro?
The first thing we would want to establish is what type of hair loss is actually occurring.
If somebody tells us they are losing hair while taking Mounjaro, Wegovy or Ozempic, we do not automatically assume the medication or weight loss is responsible.
We would start with a detailed history and scalp examination. We would usually perform trichoscopy examination of the scalp and hair follicles under magnification. This can often help distinguish between telogen effluvium, androgenetic alopecia, alopecia areata and other causes of hair loss.
Depending on the clinical picture, we may also recommend blood tests to look for potentially contributing factors such as:
Iron deficiency
Low ferritin
Vitamin D deficiency
Thyroid abnormalities
Vitamin B12 deficiency
Folate deficiency
Other nutritional issues
Not everybody experiencing hair shedding will have an underlying deficiency.
However, if significant weight loss has occurred, checking for potentially contributing factors can sometimes be useful.
In selected cases, further investigations may also be appropriate.
Not All Hair Loss On Mounjaro Is The Same
This is perhaps the most important point.
Hair loss is a symptom.
It is not a diagnosis.
Someone taking Mounjaro, Wegovy or Ozempic may develop:
Telogen effluvium
Female pattern hair loss
Male pattern hair loss
Alopecia areata
Iron deficiency related hair shedding
More than one condition at the same time
These conditions can look quite different once examined properly.
Before deciding how to treat hair loss, it is important to establish exactly what type of hair loss is occurring.
So What Is My Current View?
If a patient sitting in front of me asked whether Mounjaro, Wegovy or Ozempic cause hair loss, my answer based on what we know today would be:
“I suspect the rapid weight loss is usually the more important factor.”
That appears to be the most plausible explanation based on the evidence currently available.
However, the science is still evolving.
Future studies may show that the story is more complicated than we currently think.
For now, I think the fairest conclusion is this:
Hair shedding can occur while taking Mounjaro, Wegovy or Ozempic.
The strongest current explanation is that rapid weight loss triggers telogen effluvium rather than the medication directly affecting hair follicles.
Reference
Piraccini BM, Vañó-Galván S, Blume-Peytavi U, Ribet V, Mengeaud V.
Hair Loss in Patients on Glucagon-Like Peptide-1 Receptor Agonists: Understanding Risks and Managing Outcomes.
Dermatology and Therapy. 2026.
Available at:
Medical Disclaimer
This article is intended for educational purposes only and should not be taken as individual medical advice. If you are experiencing hair loss, speak to a suitably qualified healthcare professional.
Enjoyed this article?
Stay up to date with the latest hair loss research, emerging treatments and practical advice from Dr Gwen Adey.
Comments